Send to

Choose Destination
See comment in PubMed Commons below
Front Physiol. 2012 Jan 25;3:5. doi: 10.3389/fphys.2012.00005. eCollection 2012.

Perspectives of Targeting mTORC1-S6K1 in Cardiovascular Aging.

Author information

Laboratory of Vascular Biology, Division of Physiology, Department of Medicine, Faculty of Science, University of Fribourg Fribourg, Switzerland.


The global population aging is accelerating and age-associated diseases including cardiovascular diseases become more challenging. The underlying mechanisms of aging and age-associated cardiovascular dysfunction remain elusive. There are substantial evidences demonstrating a pivotal role of the mammalian target of rapamycin complex 1 (mTORC1) and its down-stream effector S6K1 signaling in mammalian lifespan regulation and age-related diseases such as type II diabetes mellitus and cancer. The role of mTORC1-S6K1 in age-related cardiovascular diseases is, however, largely unknown and the available experimental results are controversial. This review article primarily summarizes the most recent advances toward understanding the role of mTORC1-S6K1 in cardiovascular aging and discusses the future perspectives of targeting mTORC1-S6K1 signaling as a healthy lifespan extension modality in anti-aging and anti-cardiovascular aging.


S6K1; aging; eNOS; endothelial senescence; mTOR; oxidative stress; rapamycin; resveratrol

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontiers Media SA Icon for PubMed Central
    Loading ...
    Support Center